Granules India, Greenko ZeroC ink pact to enable carbon free energy, green molecule solutions

Hyderabad: Granules India Limited, has entered into a strategic partnership with Greenko ZeroC to collaborate for Green Molecule Solutions and its wider applications in pharmaceuticals to consolidate its position in sustainability and circular economy initiatives.

Granules & Greenko ZeroC will develop and promote State-of-the-art Integrated Green Pharmaceutical Zones (GPZ) with first collaboration in Kakinada, Andhra Pradesh.

Granules will build a green field facility based on sustainability principles for large-scale manufacturing of key starting materials (KSMs), Intermediates, APIs and fermentation based products. The facility spread across 100 acres, will be commissioned in a phase-wise manner. The estimated cost of the project will be approximately INR 2,000 Crore over five years.

Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives. Granules envisages to utilize Carbon Free Energy and Green Hydrogen derivatives to produce value-added products such as DCDA, PAP, Paracetamol, Metformin, other APIs, and Intermediates.

Granules will also manufacture energy-intensive fermentation-based products at this facility using Carbon Free Energy. This collaboration allows utilization of Fungible Carbon Offset instruments across Granules global manufacturing locations.

Commenting on the partnership, Dr. Krishna Prasad, Chairman & Managing Director, Granules, said “The partnership with Greenko will power our sustainability journey by minimizing carbon footprint and impact of our operations on the environment. Sustainability and Green chemistry are key pillars of our commitment to heal the planet and people through minimizing carbon footprint, adopting resource efficient processes, and reduce waste across our value chain”

Commenting on the partnership, Anil Kumar Chalamalasetty, CEO and Managing Director at Greenko said: “We are excited to be partnering with Granules, this innovative and pioneering partnership will propel the transformation of industrial manufacturing to be more sustainable and competitive with technologically superior and green solutions. We believe that we can herald this change in the Global Industrial landscape and this partnership with Granules is enabling such solutions in pharmaceutical industry. Such partnerships will enable Hon’ble PM Shri Modi Ji’s vision of India’s leadership in the global efforts to combat Climate Change and catalyze India’s and the world’s decarbonization”

Read also: Granules India bags USFDA okay for Guaifenesin and Pseudoephedrine Hydrochloride ER Tablets